161 related articles for article (PubMed ID: 19710685)
1. Cutaneous anaplastic large cell lymphoma and peripheral T-cell lymphoma NOS show distinct chromosomal alterations and differential expression of chemokine receptors and apoptosis regulators.
van Kester MS; Tensen CP; Vermeer MH; Dijkman R; Mulder AA; Szuhai K; Willemze R; van Doorn R
J Invest Dermatol; 2010 Feb; 130(2):563-75. PubMed ID: 19710685
[TBL] [Abstract][Full Text] [Related]
2. Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations.
Zettl A; Rüdiger T; Konrad MA; Chott A; Simonitsch-Klupp I; Sonnen R; Müller-Hermelink HK; Ott G
Am J Pathol; 2004 May; 164(5):1837-48. PubMed ID: 15111330
[TBL] [Abstract][Full Text] [Related]
3. Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines.
Fadlelmola FM; Zhou M; de Leeuw RJ; Dosanjh NS; Harmer K; Huntsman D; Lam WL; Banerjee D
Mol Cancer; 2008 Jan; 7():2. PubMed ID: 18179710
[TBL] [Abstract][Full Text] [Related]
4. Array-CGH analysis of cutaneous anaplastic large cell lymphoma.
Szuhai K; van Doorn R; Tensen CP; Van Kester
Methods Mol Biol; 2013; 973():197-212. PubMed ID: 23412792
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma.
Mao X; Orchard G; Lillington DM; Russell-Jones R; Young BD; Whittaker S
Genes Chromosomes Cancer; 2003 Jun; 37(2):176-85. PubMed ID: 12696066
[TBL] [Abstract][Full Text] [Related]
6. Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas.
Salaverria I; Beà S; Lopez-Guillermo A; Lespinet V; Pinyol M; Burkhardt B; Lamant L; Zettl A; Horsman D; Gascoyne R; Ott G; Siebert R; Delsol G; Campo E
Br J Haematol; 2008 Mar; 140(5):516-26. PubMed ID: 18275429
[TBL] [Abstract][Full Text] [Related]
7. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
[TBL] [Abstract][Full Text] [Related]
8. Array-based CGH of primary cutaneous CD8+ aggressive EPIDERMO-tropic cytotoxic T-cell lymphoma.
Fanoni D; Corti L; Alberti-Violetti S; Tensen CP; Venegoni L; Vermeer M; Willemze R; Berti E
Genes Chromosomes Cancer; 2018 Dec; 57(12):622-629. PubMed ID: 30307677
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.
Eckerle S; Brune V; Döring C; Tiacci E; Bohle V; Sundström C; Kodet R; Paulli M; Falini B; Klapper W; Chaubert AB; Willenbrock K; Metzler D; Bräuninger A; Küppers R; Hansmann ML
Leukemia; 2009 Nov; 23(11):2129-38. PubMed ID: 19657361
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative.
Kadin ME; Pinkus JL; Pinkus GS; Duran IH; Fuller CE; Onciu M; Kawaguchi H; Morris SW
Am J Surg Pathol; 2008 Sep; 32(9):1421-6. PubMed ID: 18670345
[TBL] [Abstract][Full Text] [Related]
11. High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus.
Hartmann S; Gesk S; Scholtysik R; Kreuz M; Bug S; Vater I; Döring C; Cogliatti S; Parrens M; Merlio JP; Kwiecinska A; Porwit A; Piccaluga PP; Pileri S; Hoefler G; Küppers R; Siebert R; Hansmann ML
Br J Haematol; 2010 Feb; 148(3):402-12. PubMed ID: 19863542
[TBL] [Abstract][Full Text] [Related]
12. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
13. Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma.
Xing X; Flotte TJ; Law ME; Blahnik AJ; Chng WJ; Huang G; Knudson RA; Ketterling RP; Porcher JC; Ansell SM; Sidhu J; Dogan A; Feldman AL
Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):580-9. PubMed ID: 25390351
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma.
Nelson M; Horsman DE; Weisenburger DD; Gascoyne RD; Dave BJ; Loberiza FR; Ludkovski O; Savage KJ; Armitage JO; Sanger WG
Br J Haematol; 2008 May; 141(4):461-9. PubMed ID: 18341637
[TBL] [Abstract][Full Text] [Related]
15. Pathobiology and molecular profiling of peripheral T-cell lymphomas.
de Leval L; Gaulard P
Hematology Am Soc Hematol Educ Program; 2008; ():272-9. PubMed ID: 19074096
[TBL] [Abstract][Full Text] [Related]
16. Decreased MYC-associated factor X (MAX) expression is a new potential biomarker for adverse prognosis in anaplastic large cell lymphoma.
Yamashita T; Higashi M; Momose S; Adachi A; Watanabe T; Tanaka Y; Tokuhira M; Kizaki M; Tamaru JI
Sci Rep; 2020 Jun; 10(1):10391. PubMed ID: 32587329
[TBL] [Abstract][Full Text] [Related]
17. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease.
Vermeer MH; Dukers DF; ten Berge RL; Bloemena E; Wu L; Vos W; de Vries E; Tensen CP; Meijer CJ; Willemze R
Mod Pathol; 2002 Aug; 15(8):838-44. PubMed ID: 12181269
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of Mcl-1 in T-cell non-Hodgkin's lymphoma].
Lin XB; Jiang WQ; Zhong XY; Luo RZ
Ai Zheng; 2007 Apr; 26(4):435-9. PubMed ID: 17430669
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma.
Hong JY; Hong ME; Choi MK; Chang W; Do IG; Jo JS; Jung SH; Park S; Kim SJ; Ko YH; Kim WS
Anticancer Res; 2015 Apr; 35(4):2465-74. PubMed ID: 25862915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]